Experience

Structure Therapeutics – $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner, Singapore
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Alexander Lee
Partner, Los Angeles Santa Monica
Karen Deschaine
Partner, San Diego
Jie Zhang
Partner, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Partner, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington DC
Lisa Yuan
Special Counsel, Beijing
Jennifer Shanley
Special Counsel, New York
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Yuan Dai
Associate, Shanghai
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Alexander Davis
Associate, San Diego
Brian Lau
International Legal Project Manager, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Diego

Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals

July 14, 2022

Cooley advised ViaCyte, a biotechnology company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for Type 1 diabetes (T1D), on its definitive agreement to be acquired by global biotechnology company Vertex Pharmaceuticals for $320 million in cash. Partners Rowook Park and Carlos Ramirez, along with associate Lindsey O’Crump, led the Cooley team advising ViaCyte.

Read more

Related contacts

Rowook Park
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Jacqueline Grise
Partner, Washington DC
Rama Padmanabhan
Partner, San Diego
Marty Schenker
Senior Counsel , San Francisco
Todd Gluth
Partner, San Diego
Blake Martell
Partner, San Francisco
Kay Chandler
Partner, San Diego
Charity Williams
Partner, San Diego
Cindy Lovering
Partner, San Diego
Jeffrey Karr
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
David Burns
Special Counsel, Washington DC
Dina Andrawess
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Arman Sagart
Associate, San Diego
Lindsey O'Crump
Associate, Washington DC
Melissa Meza
Associate, San Diego
Joe Mandry
Associate, San Diego
Julia R. Brinton
Associate, Washington DC
Kimberley Scimeca
Associate, Boston
Daniel Lac
Associate, San Diego
Amanda Griggs
Associate, New York

Drata Reaches Unicorn Status With Series B Round

November 15, 2021

Cooley advised Drata, a next-generation security and compliance automation company, on its $100 million Series B financing round, which brings the company’s valuation to $1 billion. Lawyers Ken Rollins, Carlos Ramirez and Dylan Kornbluth led the Cooley team advising Drata.

Read more

Related contacts

Ken Rollins
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Dylan Kornbluth
Associate, San Diego
Kate Walther
Paralegal Specialist, San Diego

The Honest Company – $475 Million IPO

May 10, 2021

Cooley advised The Honest Company, a consumer goods company founded by actress Jessica Alba, on its $475 million initial public offering of 29,678,050 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Partners Tom Hopkins, Nicole Brookshire, Siana Lowrey and Sara Semnani led the Cooley team advising Honest.

Read more

Related contacts

C. Thomas Hopkins
Partner in Charge, Los Angeles – Santa Monica
Siana Lowrey
Partner, San Francisco
Sara Semnani
Partner, Los Angeles Santa Monica
Carlos Ramirez
Partner, San Diego
Jessica Girone
Associate, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Austin Holt
Associate, Los Angeles Santa Monica
Megan Drill
Associate, San Diego
Alexander Lee
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
John Paul Oleksiuk
Partner, New York
David Navetta
Partner, Colorado
Kristopher Kleiner
Special Counsel, Colorado
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Jacqueline Grise
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
David Burns
Special Counsel, Washington DC
Matt Howsare
Partner, Washington DC
Scott Dailard
Partner, San Diego
William O'Connor
Partner, San Diego
Francis Wheeler
Partner, Colorado
Karen Tsai
Special Counsel, Washington DC
Maricel Mojares-Moore
Special Counsel, San Francisco
Greg Reith
Associate, Washington DC
Chris Rhem
Paralegal Specialist, San Francisco

MannKind – $200 Million Convertible Notes Offering

March 2, 2021

Cooley advised MannKind on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. MannKind, whose securities trade on the Nasdaq Global Market under the symbol MNKD, focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Partners Sean Clayton, Mischi a Marca and Jason Savich led the Cooley team.

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Carlos Ramirez
Partner, San Diego
Brett Dovman
Associate, San Diego
Molly Niffenegger
Associate, San Francisco
View more

Rankings & accolades

Hispanic National Bar Association: Top Lawyers Under 40

Memberships & affiliations

American Bar Association

San Diego County Bar Association

Hispanic National Bar Association